# Filing Detail

Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001140361-22-036377
Filing Date
2022-10-06
Accepted
2022-10-06 12:21:24
Documents
6
Period of Report
2022-12-01

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | PRE 14A | ny20005256x1_pre14a.htm | PRE 14A | 814157
2 |  | logo_galectin.jpg | GRAPHIC | 26119
3 |  | ny20005256x1_pc01.jpg | GRAPHIC | 749074
4 |  | ny20005256x1_pc02.jpg | GRAPHIC | 579184
5 |  | sig_jlewis.jpg | GRAPHIC | 12813
6 |  | sig_jwcallicutt.jpg | GRAPHIC | 17818
| Complete submission text file | 0001140361-22-036377.txt |  | 2721551

Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

EIN.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-31791 | Film No.: 221297577
SIC: 2834 Pharmaceutical Preparations